- 65 Equity will hold around 40% stake in the combined company
- HAS develops and produces APIs, HPAPIs and anticancer compounds
- Cerbios-Pharma manufactures chemical and biological APIs
65 Equity Partners has invested in HAS Healthcare Advanced Synthesis, an international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs) and anticancer compounds.
